Radiation Dose Management Market to Reach 505.3 Million by 2027, Advancing at 12.6% CAGR – Report by Emergen Research

Share

Tweet

Share

Share

Email

According to a recent analysis by Emergent Research, the global radiation dose management market is expected to be valued at USD 505.3 million by 2027. Throughout the anticipated era, rising healthcare facilities, driven by quickly expanding imaging gadget deployments, are anticipated to be significant drivers of the rise of the global demand for radiation dose control. Following this, it is projected that in the ensuing years, an increasing emphasis on the implementation of universal norms for radiation exposure by policy authorities will enhance radiation acceptance dose management systems.

For instance, a consensus paper on the realistic use of radiation when doing cardiovascular imaging was published in 2018 by the Heart Rhythm Society, the American College of Cardiology, the North American Society for Cardiovascular Imaging, and other organizations.

To keep track of and calculate the number of prescriptions required throughout treatment and prevent patients from receiving high radiation doses, radiation dose regulation is utilized. Patients are protected against radioactive exposure and burns brought on by radiation overdose. They are essential in lowering the radiation dosages that patients get during imaging procedures. The lack of healthcare facilities in underdeveloped nations and the increased expenses associated with implementing computerized systems, however, are likely to hinder the development of the global radiation dose management market during the forecast period.

Radiography, angiography, mammography, fluoroscopy, and interventional imaging are a few applications where diagnostic imaging is frequently employed. The incorporation of radiation exposure management technologies into these imaging applications is of great interest to numerous manufacturers of diagnostic imaging equipment. X-ray and computed tomography technologies are thought to generate a substantial amount of radiation when compared to other imaging techniques. The overall market exhibits significant growth potential due to the increased frequency of chronic diseases, effective and secure care-focused therapeutic modalities, and consumer awareness-raising.

Further key findings from the report suggest

• According to the component, the service sector produced a sizable amount of revenue in 2019 and is anticipated to grow at a CAGR of 12.9% over the forecast period as a result of patients’ growing awareness of issues like the negative effects of diagnostic imaging pollution, which has compelled healthcare facilities to carefully monitor the quality control of diagnostic ionization pollution.
• Due to their application in the reduction of ionization pollution exposure, process monitors are predicted to expand with a CAGR of 7.9% over the forecasted period. These devices support activities with high accuracy and effectiveness of radiation monitoring and warnings where a violation of permissible radiation standards arises.
• The Radiation Dose Management Market is primarily driven by the radiography application. Due to its growing usage in cancer diagnosis, which is a significant burden of disease, and its increasing prevalence because of an increase in the global elderly population, community radiography is the industry’s largest shareholder and held around 31.3% of the market in 2019.
• Key participants include Thermo Fisher Scientific Inc., Philips Healthcare, Landauer Inc., GE Healthcare, Medicvision, Bayer AG, Toshiba MSC, Sectra, Seimens Healthcare Private Limited, and Infinitt Healthcare Co. Ltd., among others.

For this report, Emergen Research has segmented the global Radiation Dose Management market based on the component, product, application, and region:

Component Outlook (Revenue, USD Million; 2017-2027)

• Software
• Service

Product Outlook (Revenue, USD Million; 2017-2027)

• Dosimeters
• Area Process Monitors
• Others

Application Outlook (Revenue, USD Million; 2017-2027)

• Radiography
• Angiography
• Mammography
• Fluoroscopy & Interventional Imaging
• Others

Regional Outlook (Revenue, USD Million; 2017-2027)

• North America
  1. the U.S.
  2. Canada
• Europe
  1. Germany
  2. the UK
  3. France
  4. Benelux
  5. Rest of Europe
• the Asia Pacific
  1. China
  2. Japan
  3. South Korea
  4. Rest of APAC
• MEA
  1. Saudi Arabia
  2. UAE
  3. Rest of MEA
• Latin America
  1. Brazil
  2. Rest of LATAM

Want to learn more about the Radiation Dose Management market growth? Request a sample Copy